Traynor Capital Management, Inc. Abbott Laboratories Transaction History

Traynor Capital Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 20, 2022	BUY	$96.76 - $112.03 $1.87 Million - $2.17 Million	19,348 New	19,348 $1.87 Million
Q2 2022 Jul 28, 2022	SELL	$102.07 - $123.37 $207,202 - $250,441	-2,030 Closed	0 $0
Q1 2022 Apr 13, 2022	SELL	$114.02 - $139.04 $16,190 - $19,743	-142 Reduced 6.54%	2,030 $240,000
Q4 2021 Feb 01, 2022	BUY	$115.53 - $141.46 $42,052 - $51,491	364 Added 20.13%	2,172 $305,000
Q3 2021 Oct 25, 2021	BUY	$116.66 - $129.06 $210,921 - $233,340	1,808 New	1,808 $213,000
Q2 2019 Jul 26, 2019	SELL	$72.88 - $85.0 $187,082 - $218,195	-2,567 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$66.22 - $80.06 $169,986 - $205,514	2,567 New	2,567 $205,000

3,361

1.36B

10.6M

8.73M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Traynor Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Traynor Capital Management, Inc. with notifications on news.